-
Actos 15 mg Tabletten
- Zulassung: European Union
- Hersteller: Takeda Global Research and Development Centre (Europe) Ltd.
- ATC-Code: A10BG03
- Anwendungsgebiet: Diabetes Mellitus
- Wirkstoff: pioglitazone, Lactose-Monohydrat
-
Actos 30 mg Tabletten
- Zulassung: European Union
- Hersteller: Takeda Global Research and Development Centre (Europe) Ltd.
- ATC-Code: A10BG03
- Anwendungsgebiet: Diabetes Mellitus
- Wirkstoff: pioglitazone, Lactose-Monohydrat
-
Actos 45 mg Tabletten
- Zulassung: European Union
- Hersteller: Takeda Global Research and Development Centre (Europe) Ltd.
- ATC-Code: A10BG03
- Anwendungsgebiet: Diabetes Mellitus
- Wirkstoff: pioglitazone, Lactose-Monohydrat
-
Competact 15 mg/850 mg Filmtabletten
- Zulassung: European Union
- Hersteller: Takeda Global Research and Development Centre (Europe) Ltd.
- ATC-Code: A10BD05
- Anwendungsgebiet: Diabetes Mellitus
- Wirkstoff: pioglitazone, metformin hydrochloride, Metforminhydrochlorid
-
Glubrava 15 mg/850 mg Filmtabletten
- Zulassung: European Union
- Hersteller: Takeda Global Research and Development Centre (Europe) Ltd.
- ATC-Code: A10BD05
- Anwendungsgebiet: Diabetes Mellitus
- Wirkstoff: pioglitazone, metformin hydrochloride, Metforminhydrochlorid
-
Glustin 15 mg Tabletten
- Zulassung: European Union
- Hersteller: Takeda Global Research and Development Centre (Europe) Ltd.
- ATC-Code: A10BG03
- Anwendungsgebiet: Diabetes Mellitus
- Wirkstoff: pioglitazone, Lactose-Monohydrat
-
Glustin 30 mg Tabletten
- Zulassung: European Union
- Hersteller: Takeda Global Research and Development Centre (Europe) Ltd.
- ATC-Code: A10BG03
- Anwendungsgebiet: Diabetes Mellitus
- Wirkstoff: pioglitazone, Lactose-Monohydrat
-
Glustin 45 mg Tabletten
- Zulassung: European Union
- Hersteller: Takeda Global Research and Development Centre (Europe) Ltd.
- ATC-Code: A10BG03
- Anwendungsgebiet: Diabetes Mellitus
- Wirkstoff: pioglitazone, Lactose-Monohydrat
-
Tandemact 30 mg/2 mg Tabletten
- Zulassung: European Union
- Hersteller: Takeda Global Research and Development Centre (Europe) Ltd.
- ATC-Code: A10BD06
- Anwendungsgebiet: Diabetes Mellitus
- Wirkstoff: pioglitazone, glimepiride, Lactose-Monohydrat, Glimepirid
-
Tandemact 30 mg/4 mg Tabletten
- Zulassung: European Union
- Hersteller: Takeda Global Research and Development Centre (Europe) Ltd.
- ATC-Code: A10BD06
- Anwendungsgebiet: Diabetes Mellitus
- Wirkstoff: pioglitazone, glimepiride, Lactose-Monohydrat, Glimepirid
-
Tandemact 45 mg/4 mg Tabletten
- Zulassung: European Union
- Hersteller: Takeda Global Research and Development Centre (Europe) Ltd.
- ATC-Code: A10BD06
- Anwendungsgebiet: Diabetes Mellitus
- Wirkstoff: pioglitazone, glimepiride, Lactose-Monohydrat, Glimepirid